AMPSOURCE BIOPHARMA SHANGHAI INC has a total of 28 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and agriculture are UNUM THERAPEUTICS INC, ICELL GENE THERAPEUTICS LLC and IMMUNEONCO BIOPHARMACEUTICALS SHANGHAI CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | United States | 5 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Republic of Korea | 3 | |
#5 | Russian Federation | 2 | |
#6 | Australia | 1 | |
#7 | Brazil | 1 | |
#8 | Canada | 1 | |
#9 | China | 1 | |
#10 | United Kingdom | 1 | |
#11 | Mexico | 1 | |
#12 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Agriculture | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Animal care | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Li Qiang | 26 |
#2 | Li Yuanli | 20 |
#3 | Ma Xinlu | 17 |
#4 | Zheng Yuncheng | 16 |
#5 | Xiao Liang | 8 |
#6 | Xue Tongtong | 8 |
#7 | Liu Dengnian | 8 |
#8 | Gao Yongjuan | 8 |
#9 | Sun Jianyu | 7 |
#10 | Hu Jiangjiang | 7 |
Publication | Filing date | Title |
---|---|---|
WO2021012947A1 | Fgf21 fc fusion protein, glp-1 fc fusion protein, and combination therapeutic agent comprising same and use thereof | |
WO2020063562A1 | Fusion protein of mutated single-chain human coagulation factor viii, preparation method therefor, and use thereof | |
CN111886023A | Antibodies to TIM-3 and uses thereof | |
US2020347131A1 | Anti-lag-3 antibody and use thereof | |
KR20190117493A | Anti PD-1 Antibodies and Uses thereof | |
US2019365867A1 | Highly glycosylated human blood-clotting factor viii fusion protein, and manufacturing method and application of same | |
EP3502143A1 | Linker peptide for constructing fusion protein |